Additional file 1: of Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients
Nicola Gianotti
Andrea Poli
Silvia Nozza
Laura Galli
Nadia Galizzi
Marco Ripa
Marco Merli
Alessia Carbone
Vincenzo Spagnuolo
Adriano Lazzarin
Antonella Castagna
10.6084/m9.figshare.c.3932917_D1.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Durability_of_switch_regimens_based_on_rilpivirine_or_on_integrase_inhibitors_both_in_association_with_tenofovir_and_emtricitabine_in_HIV-infected_virologically_suppressed_patients/5611495
Specific PIs and NNRTIs ongoing at baseline. (DOCX 12Â kb)
2017-11-16 05:00:00
Rilpivirine
Raltegravir
Elvitegravir/cobicistat
Dolutegravir
Non-nucleoside reverse transcriptase inhibitors
Integrase inhibitors
Switch regimen
Residual viremia
Virological suppression